SynthesisLipids in health and disease2025

Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease.

Xiaohui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.